ISSN : 2146-3123
E-ISSN : 2146-3131

Mahmut Büyükşimşek1, Semra Paydaş1, Ali Oğul1, Emine Bağır2, Melek Ergin2
1Department of Oncology, Çukurova University School of Medicine, Adana, Turkey
2Department of Pathology, Çukurova University School of Medicine, Adana, Turkey
DOI : 10.4274/balkanmedj.2017.0600

Background: Thyroid cancer is the most common endocrine cancers with an increasing incidence around the world in the last three decades. The increased risk of secondary cancer is associated with genetic predisposition or radioactive iodine (RAI) used in the treatment.
Case Report: 65-year old male patient was operated for thyroid papillary cancer. Total thyroidectomy was performed. He received RAI two times. After six years he presented with eosinophilic myeloproliferative neoplasia and T-cell lymphoblastic leukemia/lymphoma, together.
Conclusion: Leukemia and other hematologic malignancies may develop after RAI treatment. However, we present this case because there was no case reported in the literature that developed myeloid neoplasia and T-cell lymphoblastic lymphoma associated with eosinophilia after RAI.

Keywords :

Viewed : 454
Downloaded : 137